questionsmedicales.fr
Structures macromoléculaires
Complexes multiprotéiques
Inflammasomes
Inflammasomes : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Inflammasomes
Interleukines
Symptômes
5
Arthrite
Maladies auto-immunes
Maladie d'Alzheimer
Troubles neurologiques
Âge
Conditions sous-jacentes
Prévention
5
Mode de vie
Alimentation équilibrée
Maladies auto-immunes
Suivi médical
Exercice physique
Inflammation
Compléments alimentaires
Oméga-3
Traitements
5
Anti-inflammatoires
Interleukines
Corticostéroïdes
Inflammation
Inhibiteurs
Recherche clinique
Thérapie génique
Voies de signalisation
Complications
5
Maladies chroniques
Troubles métaboliques
Cancers
Activation chronique
Santé cardiovasculaire
Inflammation vasculaire
Maladies neurodégénératives
Maladie d'Alzheimer
Traitement
Changements de mode de vie
Facteurs de risque
5
Âge
Inflammation chronique
Infections virales
Inflammation
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Inflammasomes : Questions médicales les plus fréquentes",
"headline": "Inflammasomes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Inflammasomes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-24",
"dateModified": "2025-03-19",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Inflammasomes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Complexes multiprotéiques",
"url": "https://questionsmedicales.fr/mesh/D046912",
"about": {
"@type": "MedicalCondition",
"name": "Complexes multiprotéiques",
"code": {
"@type": "MedicalCode",
"code": "D046912",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D05.500"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Inflammasomes",
"alternateName": "Inflammasomes",
"code": {
"@type": "MedicalCode",
"code": "D058847",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Thirumala-Devi Kanneganti",
"url": "https://questionsmedicales.fr/author/Thirumala-Devi%20Kanneganti",
"affiliation": {
"@type": "Organization",
"name": "Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Electronic address: Thirumala-Devi.Kanneganti@StJude.org."
}
},
{
"@type": "Person",
"name": "Guang Xu",
"url": "https://questionsmedicales.fr/author/Guang%20Xu",
"affiliation": {
"@type": "Organization",
"name": "China Military Institute of Chinese Materia, The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, 100039, China."
}
},
{
"@type": "Person",
"name": "Zhilei Wang",
"url": "https://questionsmedicales.fr/author/Zhilei%20Wang",
"affiliation": {
"@type": "Organization",
"name": "China Military Institute of Chinese Materia, The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, 100039, China."
}
},
{
"@type": "Person",
"name": "Xiaohe Xiao",
"url": "https://questionsmedicales.fr/author/Xiaohe%20Xiao",
"affiliation": {
"@type": "Organization",
"name": "Integrative Medical Centre, The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, 100039, China. pharmacy_302@126.com."
}
},
{
"@type": "Person",
"name": "Zhaofang Bai",
"url": "https://questionsmedicales.fr/author/Zhaofang%20Bai",
"affiliation": {
"@type": "Organization",
"name": "China Military Institute of Chinese Materia, The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, 100039, China. baizf2008@hotmail.com."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Completeness of variables in Hospital-Based Cancer Registries for prostatic malignant neoplasm.",
"datePublished": "2024-07-29",
"url": "https://questionsmedicales.fr/article/39082550",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/0034-7167-2023-0467"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hepatic Small Vessel Neoplasm Mimics Prostate Cancer on 18 F-DCFPyl PET/CT.",
"datePublished": "2023-01-14",
"url": "https://questionsmedicales.fr/article/36728165",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/RLU.0000000000004554"
}
},
{
"@type": "ScholarlyArticle",
"name": "Granulomatous prostatitis: mimicking locally advanced prostate adenocarcinoma.",
"datePublished": "2023-10-17",
"url": "https://questionsmedicales.fr/article/37850783",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.23750/abm.v94i5.13751"
}
},
{
"@type": "ScholarlyArticle",
"name": "Clinicopathological and immunological profiles of prostate adenocarcinoma and neuroendocrine prostate cancer.",
"datePublished": "2022-12-27",
"url": "https://questionsmedicales.fr/article/36572885",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12957-022-02841-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "The influence of prostate volume on clinical parameters in prostate cancer screening.",
"datePublished": "2022-09-13",
"url": "https://questionsmedicales.fr/article/36098911",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jcla.24700"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Structures macromoléculaires",
"item": "https://questionsmedicales.fr/mesh/D046911"
},
{
"@type": "ListItem",
"position": 3,
"name": "Complexes multiprotéiques",
"item": "https://questionsmedicales.fr/mesh/D046912"
},
{
"@type": "ListItem",
"position": 4,
"name": "Inflammasomes",
"item": "https://questionsmedicales.fr/mesh/D058847"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Inflammasomes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Inflammasomes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Inflammasomes",
"description": "Comment diagnostiquer une activation des inflammasomes ?\nQuels tests sont utilisés pour évaluer les inflammasomes ?\nLes biopsies peuvent-elles aider au diagnostic ?\nQuels symptômes peuvent indiquer une activation des inflammasomes ?\nY a-t-il des marqueurs spécifiques pour les inflammasomes ?",
"url": "https://questionsmedicales.fr/mesh/D058847?mesh_terms=Prostatic+Neoplasms#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Inflammasomes",
"description": "Quels sont les symptômes d'une inflammation liée aux inflammasomes ?\nLes inflammasomes sont-ils liés à des maladies spécifiques ?\nComment les inflammasomes affectent-ils la fièvre ?\nPeut-on observer des symptômes neurologiques ?\nLes symptômes varient-ils selon l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D058847?mesh_terms=Prostatic+Neoplasms#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Inflammasomes",
"description": "Comment prévenir l'activation des inflammasomes ?\nLes vaccins peuvent-ils prévenir l'activation des inflammasomes ?\nY a-t-il des mesures spécifiques pour les maladies auto-immunes ?\nL'exercice physique aide-t-il à prévenir l'inflammation ?\nLes compléments alimentaires sont-ils utiles ?",
"url": "https://questionsmedicales.fr/mesh/D058847?mesh_terms=Prostatic+Neoplasms#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Inflammasomes",
"description": "Quels traitements ciblent les inflammasomes ?\nLes corticostéroïdes sont-ils efficaces contre les inflammasomes ?\nY a-t-il des traitements expérimentaux ?\nComment la diète influence-t-elle les inflammasomes ?\nLes thérapies géniques sont-elles une option ?",
"url": "https://questionsmedicales.fr/mesh/D058847?mesh_terms=Prostatic+Neoplasms#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Inflammasomes",
"description": "Quelles complications peuvent survenir avec l'activation des inflammasomes ?\nLes inflammasomes sont-ils liés à des cancers ?\nComment les inflammasomes affectent-ils la santé cardiovasculaire ?\nY a-t-il des risques neurologiques associés ?\nLes complications sont-elles réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D058847?mesh_terms=Prostatic+Neoplasms#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Inflammasomes",
"description": "Quels sont les principaux facteurs de risque pour l'activation des inflammasomes ?\nL'âge influence-t-il le risque d'activation des inflammasomes ?\nLe stress psychologique est-il un facteur de risque ?\nLes infections virales augmentent-elles le risque ?\nY a-t-il un lien entre la génétique et les inflammasomes ?",
"url": "https://questionsmedicales.fr/mesh/D058847?mesh_terms=Prostatic+Neoplasms#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une activation des inflammasomes ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests biologiques mesurant les cytokines et l'inflammation."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les inflammasomes ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de laboratoire comme la mesure de l'IL-1β et des marqueurs inflammatoires sont utilisés."
}
},
{
"@type": "Question",
"name": "Les biopsies peuvent-elles aider au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les biopsies peuvent révéler des signes d'inflammation et d'activation des inflammasomes."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une activation des inflammasomes ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la fièvre, la douleur et l'inflammation peuvent indiquer une activation."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs spécifiques pour les inflammasomes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des marqueurs comme l'ASC et le caspase-1 peuvent être utilisés pour évaluer l'activation."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une inflammation liée aux inflammasomes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleur, rougeur, chaleur et gonflement au site d'inflammation."
}
},
{
"@type": "Question",
"name": "Les inflammasomes sont-ils liés à des maladies spécifiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont impliqués dans des maladies comme l'arthrite, le diabète et les maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Comment les inflammasomes affectent-ils la fièvre ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent induire la production de cytokines pro-inflammatoires, provoquant de la fièvre."
}
},
{
"@type": "Question",
"name": "Peut-on observer des symptômes neurologiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'activation des inflammasomes peut être liée à des troubles neurologiques comme l'Alzheimer."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de l'âge et de la condition sous-jacente."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'activation des inflammasomes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un mode de vie sain, éviter le stress et une alimentation équilibrée peuvent aider."
}
},
{
"@type": "Question",
"name": "Les vaccins peuvent-ils prévenir l'activation des inflammasomes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains vaccins peuvent réduire le risque d'infections et donc l'activation des inflammasomes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures spécifiques pour les maladies auto-immunes ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pour les maladies auto-immunes, un suivi médical régulier et un traitement préventif sont essentiels."
}
},
{
"@type": "Question",
"name": "L'exercice physique aide-t-il à prévenir l'inflammation ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut réduire l'inflammation et l'activation des inflammasomes."
}
},
{
"@type": "Question",
"name": "Les compléments alimentaires sont-ils utiles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains compléments comme les oméga-3 peuvent aider à moduler l'inflammation."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les inflammasomes ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des inhibiteurs comme les anti-IL-1 et les médicaments anti-inflammatoires sont utilisés."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes sont-ils efficaces contre les inflammasomes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les corticostéroïdes peuvent réduire l'inflammation liée à l'activation des inflammasomes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements expérimentaux incluent des inhibiteurs spécifiques des inflammasomes en recherche."
}
},
{
"@type": "Question",
"name": "Comment la diète influence-t-elle les inflammasomes ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une diète riche en antioxydants peut réduire l'activation des inflammasomes et l'inflammation."
}
},
{
"@type": "Question",
"name": "Les thérapies géniques sont-elles une option ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies géniques ciblant les voies des inflammasomes sont en cours d'étude."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'activation des inflammasomes ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des maladies chroniques comme l'arthrite et des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Les inflammasomes sont-ils liés à des cancers ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'activation chronique des inflammasomes peut être associée à certains types de cancer."
}
},
{
"@type": "Question",
"name": "Comment les inflammasomes affectent-ils la santé cardiovasculaire ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent contribuer à l'inflammation vasculaire, augmentant le risque de maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques neurologiques associés ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'activation des inflammasomes est liée à des maladies neurodégénératives comme l'Alzheimer."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié et des changements de mode de vie."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque pour l'activation des inflammasomes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'obésité, le diabète, le tabagisme et les infections chroniques."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'activation des inflammasomes ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente avec l'âge en raison de l'inflammation chronique associée."
}
},
{
"@type": "Question",
"name": "Le stress psychologique est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut exacerber l'inflammation et activer les inflammasomes."
}
},
{
"@type": "Question",
"name": "Les infections virales augmentent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections virales peuvent activer les inflammasomes et provoquer une inflammation."
}
},
{
"@type": "Question",
"name": "Y a-t-il un lien entre la génétique et les inflammasomes ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des variations génétiques peuvent prédisposer certains individus à une activation des inflammasomes."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 19/03/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Electronic address: Thirumala-Devi.Kanneganti@StJude.org.
Publications dans "Inflammasomes" :
3 publications dans cette catégorie
Affiliations :
China Military Institute of Chinese Materia, The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, 100039, China.
Publications dans "Inflammasomes" :
3 publications dans cette catégorie
Affiliations :
China Military Institute of Chinese Materia, The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, 100039, China.
School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
Publications dans "Inflammasomes" :
3 publications dans cette catégorie
Affiliations :
Integrative Medical Centre, The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, 100039, China. pharmacy_302@126.com.
Publications dans "Inflammasomes" :
3 publications dans cette catégorie
Affiliations :
China Military Institute of Chinese Materia, The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, 100039, China. baizf2008@hotmail.com.
Publications dans "Inflammasomes" :
2 publications dans cette catégorie
Affiliations :
Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, U.K.
Publications dans "Inflammasomes" :
2 publications dans cette catégorie
Affiliations :
Departamento de Imunologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brasil. alepontillo@usp.br.
Publications dans "Inflammasomes" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacology & Toxicology, School of Biomedical Sciences, Department of Chemistry, University of Otago, Dunedin, New Zealand.
Publications dans "Inflammasomes" :
2 publications dans cette catégorie
Affiliations :
Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Halal Research Center of IRI, FDA, Tehran, Iran; Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran. Electronic address: sahebkara@mums.ac.ir.
Publications dans "Inflammasomes" :
2 publications dans cette catégorie
Affiliations :
China Military Institute of Chinese Materia, The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, 100039, China.
School of Pharmacy, Jiangxi University of Traditional Chinese Medicine, Nanchang, 330004, China.
Publications dans "Inflammasomes" :
2 publications dans cette catégorie
Affiliations :
Integrative Medical Centre, The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, 100039, China.
Publications dans "Inflammasomes" :
2 publications dans cette catégorie
Affiliations :
China Military Institute of Chinese Materia, The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, 100039, China.
Publications dans "Inflammasomes" :
2 publications dans cette catégorie
Affiliations :
China Military Institute of Chinese Materia, The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, 100039, China.
Publications dans "Inflammasomes" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology and Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA. Electronic address: gabriel.nunez@umich.edu.
Publications dans "Inflammasomes" :
1 publication dans cette catégorie
Affiliations :
Program in Innate Immunity, Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Publications dans "Inflammasomes" :
1 publication dans cette catégorie
Affiliations :
Program in Innate Immunity, Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA. Electronic address: kate.fitzgerald@umassmed.edu.
Publications dans "Inflammasomes" :
1 publication dans cette catégorie
Affiliations :
The Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, Antrim, U.K.
Publications dans "Inflammasomes" :
1 publication dans cette catégorie
Affiliations :
Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, U.K.
Publications dans "Inflammasomes" :
1 publication dans cette catégorie
Affiliations :
The Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, Antrim, U.K.
Publications dans "Inflammasomes" :
1 publication dans cette catégorie
Affiliations :
Toyama Prefectural Institute for Pharmaceutical Research, Japan. Electronic address: takatsuk@ems.u-toyama.ac.jp.
Publications dans "Inflammasomes" :
to analyze the completeness of variables from Hospital-Based Cancer Registries of cases of prostate neoplasm in the Oncology Care Network of a Brazilian state between 2000 and 2020....
an ecological time series study, based on secondary data on prostate cancer Hospital-Based Cancer Registries prostate. Data incompleteness was classified as excellent (<5%), good (between 5%-10%), fai...
there were 13,519 cases of prostate cancer in the Hospital-Based Cancer Registries analyzed. The variables "family history of cancer" (p<0.001), "alcoholism" (p<0.001), "smoking" (p<0.001), "TNM stagi...
most Hospital-Based Cancer Registries variables showed excellent completeness, but important variables had high percentages of incompleteness, such as TNM and clinical staging, in addition to alcoholi...
18 F-DCFPyl is a Food and Drug Administration-approved radiotracer that targets prostate-specific membrane antigen and is used in the detection of recurrent or metastatic prostate cancer. As its use h...
We report the case of a 63-year-old male who came to the urology clinic with an increasing value of the prostate specific antigen and an asymmetrical enlargement at the digital rectal examination. The...
Biomarkers of DNA damage repair deficiency provide opportunities for personalized treatment with immunotherapy. However, there is limited research on the immune microenvironment of adeno-neuroendocrin...
A retrospective medical record review of 66 patients with prostate cancer (PCa) was performed. PCa samples from the 66 patients were analyzed using immunohistochemical staining for the detection of ch...
Twenty patients presented with adeno-NEPC, whereas 46 presented with adeno-PCa. The median age of patients at PCa diagnosis was 67.86 ± 7.05 years (68.65 ± 7.23 years, adeno-NEPC; 67.52 ± 7.02 years, ...
Our study revealed clinicopathological manifestations of adeno-NEPC and some possible predictive factors significantly associated with better outcomes in patients with adeno-NEPC. These findings might...
The purpose of the study was to evaluate the diagnostic significance of two new and a few clinical markers for prostate cancer (PCa) at various prostate volumes (PV)....
The study subjects were divided into two groups. Among them, there were 70 cases in the PV ≤30 ml group (benign prostatic hyperplasia [BPH]: 32 cases, PCa: 38 cases) and 372 cases in the PV > 30 ml gr...
In the PV ≤30 ml group, the diagnostic parameters based on prostate-specific antigen (PSA) had a decreased diagnostic significance for PCa. In the PV > 30 ml group, PSAD (AUC = 0.709), AVR (AVR = Age/...
Choosing appropriate indicators for different PVs could contribute to the early screening and diagnosis of PCa. The difference in the diagnostic value of two new indicators (A-PSAD and AVR), and PSAD ...
The optimal treatment of metastatic castration-resistant prostate cancer (mCRPC) continues to be challenging, given the multitude of life prolonging treatment options. Radionuclide therapy delivers co...
This study aims to compare the ability of the PHI versus tPSA test to predict the presence of PCa in our population....
A prospective observational study was performed. We included patients with tPSA ≥ 2.5 ng/ml, biopsy naïve or previous negative biopsy, undergoing a blood test, which includes tPSA, fPSA, and p2PSA, an...
140 men were included. Fifty-seven (40.7%) had a positive prostate biopsy result (Group A), and 83 (59.3%) had a negative biopsy result (Group B). The mean age was similar in both groups (mean ± stand...
The PHI test improves PCa detection compared to tPSA in our population....
Holmium laser enucleation of the prostate (HoLEP) is a size-independent surgical option for treating benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) with excellent, durable ...
Noninvasive methods for the early identify diagnosis of prostatitis, benign prostatic hyperplasia (BPH), and prostate cancer (PCa) are current clinical challenges....
The serum metabolites of 20 healthy individuals and patients with prostatitis, BPH, or PCa were identified using untargeted liquid chromatography-mass spectrometry (LC-MS). In addition, targeted LC-MS...
Organic acid metabolites had good sensitivity and specificity in differentiating prostatitis, BPH, and PCa. Three diagnostic models identified patients with PROSTATITIS: phenyllactic acid (area under ...
We compare Prostate Health Index, Prostate Health Index density, and PSA density in predicting clinically significant prostate cancer in MRI-guided prostate biopsy....
This is a multicenter evaluation of prospectively maintained prostate biopsy databases at 10 urology centers. Men with Prostate Health Index and MRI-guided targeted and systematic prostate biopsy perf...
A total of 1,215 men were analyzed. Prostate cancer and clinically significant prostate cancer were diagnosed in 51% (617/1,215) and 35% (422/1,215) of men, respectively. Clinically significant prosta...
Prostate Health Index density outperformed Prostate Health Index or PSA density in clinically significant prostate cancer detection in men with multiparametric MRI performed, and further reduced unnec...